Physician profile
Rita Gupta
NPI 1003857269
$11,330.47
in general payments reported to CMS, 2019-2025
73 companies · $2,035 in 2025
The $2,035 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $836 · 2020: $287 · 2021: $208 · 2022: $1,397 · 2023: $3,712 · 2024: $2,855 · 2025: $2,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,508 · Education: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,507.78 |
| Education | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $884.04 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $863.58 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Janssen Biotech, INC. | $740.23 | 2019-2025 | Darzalex, Tecvayli, Talvey |
| Pfizer INC. | $682.03 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $511.93 | 2019-2025 | Enhertu, Imfinzi, Calquence |
| Daiichi Sankyo INC. | $483.28 | 2020-2025 | Enhertu, Vanflyta |
| Astellas Pharma US INC | $459.81 | 2019-2025 | Padcev, Xtandi, Vyloy |
| Genentech USA, INC. | $440.99 | 2019-2025 | Polivy, Venclexta, Lunsumio |
| Incyte Corporation | $319.67 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Abbvie INC. | $291.98 | 2022-2025 | |
| Seagen INC. | $264.33 | 2019-2023 | Tivdak, Adcetris |
| Takeda Pharmaceuticals U.S.A., INC. | $263.85 | 2022-2024 | Fruzaqla, Iclusig, Alunbrig |
| Beigene USA, INC. | $256.16 | 2022-2024 | Brukinsa |
| Lilly USA, LLC | $222.55 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Genzyme Corporation | $220.00 | 2022-2023 |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharmaessentia USA Corporation | $212.26 | 2022-2025 | Besremi |
| Exelixis INC. | $201.42 | 2023-2025 | Cabometyx |
| Eisai INC. | $200.13 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $181.64 | 2019-2025 | Opdivo, Eliquis |
| Array Biopharma INC | $175.47 | 2022-2025 | Mektovi, Braftovi, Lorbrena |
| Amgen INC. | $167.59 | 2019-2023 | Lumakras, Kyprolis, Blincyto |
| Celgene Corporation | $148.03 | 2019-2024 | Reblozyl |
| Alexion Pharmaceuticals, INC. | $146.46 | 2022-2025 | Ultomiris |
| Pharmacyclics LLC, An Abbvie Company | $145.95 | 2022-2023 | Imbruvica, Epkinly |
| Rigel Pharmaceuticals, INC. | $141.48 | 2019-2024 | Rezlidhia, Tavalisse |
| Stemline Therapeutics INC. | $138.14 | 2023-2025 | Orserdu |
| Regeneron Healthcare Solutions, INC. | $137.79 | 2023 | Libtayo |
| Puma Biotechnology, INC. | $123.99 | 2020-2025 | Nerlynx |
| Tactile Systems Technology INC | $119.60 | 2024 | Entre Plus, Flexitouch Plus |
| Bayer Healthcare Pharmaceuticals INC. | $116.46 | 2019-2024 | |
| Glaxosmithkline, LLC. | $114.18 | 2022-2025 | Zejula, Jemperli |
| Ipsen Biopharmaceuticals, INC | $104.95 | 2023-2025 | Somatuline Depot, Onivyde, Tazverik |
| Gilead Sciences, INC. | $104.50 | 2021-2025 | Trodelvy |
| Genmab U.S., INC. | $100.68 | 2024-2025 | Epkinly |
| Taiho Oncology, INC. | $93.17 | 2022-2023 | |
| Beone Medicines USA, INC. | $91.96 | 2025 | Brukinsa, Tevimbra |
| Adc Therapeutics America, INC. | $81.33 | 2023-2025 | |
| Mirati Therapeutics, INC. | $78.91 | 2024 | Krazati |
| Emd Serono, INC. | $70.30 | 2019-2025 | |
| Eusa Pharma (US) LLC | $62.53 | 2019-2022 | |
| Kyowa Kirin, INC. | $60.85 | 2023-2024 | Poteligeo |
| Sumitomo Pharma America, INC. | $59.60 | 2023-2024 | Orgovyx |
| Aveo Pharmaceuticals, INC. | $58.33 | 2023-2025 | Fotivda |
| Deciphera Pharmaceuticals INC. | $57.94 | 2024-2025 | Qinlock, Tgct, Romvimza |
| Sobi, INC | $56.11 | 2022-2025 | |
| Heron Therapeutics, INC. | $54.07 | 2022-2023 | Sustol |
| Tersera Therapeutics LLC | $53.71 | 2023 | Xermelo, Quzyttir |
| Tempus Ai, INC | $49.04 | 2024 | Xt Cdx |
| Pharmacosmos Therapeutics INC. | $46.55 | 2023-2024 | Monoferric |
| Morphosys, US INC. | $46.39 | 2023 | Monjuvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.56 | 2023-2025 | |
| Blueprint Medicines Corporation | $43.73 | 2023 | Ayvakit |
| Janssen Pharmaceuticals, INC | $41.49 | 2019 | |
| Blue Earth Diagnostics | $34.70 | 2023 | |
| Cti Biopharma Corp. | $32.56 | 2022-2023 | Vonjo |
| Servier Pharmaceuticals LLC | $31.94 | 2022-2024 | |
| Acrotech Biopharma INC. | $30.55 | 2024-2025 | Beleodaq |
| Alnylam Pharmaceuticals INC. | $29.65 | 2023-2025 | Givlaari |
| Adaptive Biotechnologies Corporation | $28.14 | 2024 | Clonoseq |
| Novocure INC. | $27.93 | 2025 | Optune Lua (Novottf-200t) |
| Geron Corporation | $27.34 | 2025 | Rytelo |
| Sirtex Medical INC | $26.93 | 2024 | Sir-Spheres Microspheres |
| Myovant Sciences INC. | $23.80 | 2022 | |
| Springworks Therapeutics, INC. | $22.90 | 2024 | Ogsiveo |
| Verastem, INC. | $22.29 | 2019 | |
| Cycle Pharmaceuticals INC | $22.29 | 2025 | Phyrago |
| Accord Healthcare, INC. | $21.26 | 2025 | |
| Karyopharm Therapeutics INC. | $20.77 | 2020 | |
| Agios Pharmaceuticals, INC. | $20.67 | 2019 | |
| Portola Pharmaceuticals, LLC | $20.55 | 2019 | |
| Spectrum Pharmaceuticals INC. | $20.53 | 2023 | Rolvedon |
| Caris Mpi, INC. | $16.65 | 2025 | Mi Cancer Seek |
| Myriad Genetic Laboratories, INC. | $13.30 | 2022 |
Drugs and devices associated with these payments
Keytruda $661Enhertu $530Darzalex $278Tecvayli $273Venclexta $262Talvey $246Brukinsa $235Imbruvica $213Kisqali $213Cabometyx $201Verzenio $194Jaypirca $191Besremi $188Xtandi $167Lynparza $165Braftovi $156Mektovi $156Lenvima $155Lorbrena $155Adcetris $153Padcev $152Polivy $151Imfinzi $148Orserdu $138Libtayo $138Epkinly $128Scemblix $126Monjuvi $123Ultomiris $122Orgovyx $121Flexitouch Plus $120Entre Plus $120Elrexfio $113Ibrance $111Eliquis $107Pluvicto $104Lunsumio $101Jakafi $90.04Jemperli $89.30Zejula $89.30Opdivo $88.98Tukysa $84.53Retevmo $84.45Fruzaqla $82.99Somatuline Depot $80.81Onivyde $80.81Krazati $78.91Tavalisse $77.10Rezlidhia $77.10Iclusig $74.66Bosulif $74.58Sarclisa $74.27Keytruda Qlex $73.69Lonsurf $73.45Inqovi $73.45Promacta $69.94Stivarga $68.67Tivdak $67.20Welireg $66.74Inlyta $65.82Fabhalta $63.34Talzenna $62.87Poteligeo $60.85Fotivda $58.33Qinlock $57.94Alunbrig $55.40Piqray $55.22Lutathera $54.80Nubeqa $54.49Xofigo $54.49Xalkori $54.45Gazyva $52.97Trodelvy $52.66Calquence $52.57Erleada $51.57Lumakras $50.15Paxlovid $48.63Columvi $48.50Blincyto $47.54Kyprolis $47.54Phesgo $47.01Monoferric $46.55Reblozyl $45.43Bavencio $45.36Ayvakit $43.73Vitrakvi $40.28Vyloy $40.07Oxbryta $39.89Carvykti $39.88Vonjo $36.76Posluma $34.70Axumin $34.70Jevtana $33.23Mekinist $32.35Nerlynx $30.96Beleodaq $30.55Givlaari $29.65Vanflyta $29.53Xermelo $29.16Sustol $29.11
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.